R. O. Peckinpaugh

408 total citations
22 papers, 281 citations indexed

About

R. O. Peckinpaugh is a scholar working on Infectious Diseases, Genetics and Epidemiology. According to data from OpenAlex, R. O. Peckinpaugh has authored 22 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Genetics and 7 papers in Epidemiology. Recurrent topics in R. O. Peckinpaugh's work include Virus-based gene therapy research (8 papers), Viral gastroenteritis research and epidemiology (6 papers) and Bacterial Infections and Vaccines (5 papers). R. O. Peckinpaugh is often cited by papers focused on Virus-based gene therapy research (8 papers), Viral gastroenteritis research and epidemiology (6 papers) and Bacterial Infections and Vaccines (5 papers). R. O. Peckinpaugh collaborates with scholars based in United States, India and France. R. O. Peckinpaugh's co-authors include W. E. Pierce, Leonard F. Devine, E. A. Edwards, S L Rhode, Earl A. Edwards, George Gee Jackson, David Johnson, Charles H. Miller, Thomas M. Floyd and Richard B. Pollard and has published in prestigious journals such as JAMA, The Journal of Immunology and American Journal of Epidemiology.

In The Last Decade

R. O. Peckinpaugh

21 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. O. Peckinpaugh United States 10 162 91 71 62 27 22 281
H Meguro Japan 8 217 1.3× 46 0.5× 87 1.2× 38 0.6× 27 1.0× 64 356
C. R. Gregg United States 8 151 0.9× 154 1.7× 83 1.2× 26 0.4× 36 1.3× 10 365
R. L. Muldoon United States 10 172 1.1× 15 0.2× 115 1.6× 80 1.3× 50 1.9× 18 329
Jackson Gg 12 158 1.0× 18 0.2× 92 1.3× 13 0.2× 42 1.6× 28 344
P Varughese Canada 10 168 1.0× 78 0.9× 58 0.8× 10 0.2× 22 0.8× 26 280
Erna Lund Denmark 11 226 1.4× 98 1.1× 61 0.9× 9 0.1× 21 0.8× 30 346
Paul F. Frank United States 9 83 0.5× 37 0.4× 64 0.9× 15 0.2× 25 0.9× 15 223
I Horwitz Chile 10 242 1.5× 214 2.4× 62 0.9× 15 0.2× 12 0.4× 12 410
Nichols Dr 8 84 0.5× 25 0.3× 202 2.8× 10 0.2× 35 1.3× 21 332
Ira Leviton United States 7 130 0.8× 24 0.3× 171 2.4× 21 0.3× 53 2.0× 12 332

Countries citing papers authored by R. O. Peckinpaugh

Since Specialization
Citations

This map shows the geographic impact of R. O. Peckinpaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. O. Peckinpaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. O. Peckinpaugh more than expected).

Fields of papers citing papers by R. O. Peckinpaugh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. O. Peckinpaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. O. Peckinpaugh. The network helps show where R. O. Peckinpaugh may publish in the future.

Co-authorship network of co-authors of R. O. Peckinpaugh

This figure shows the co-authorship network connecting the top 25 collaborators of R. O. Peckinpaugh. A scholar is included among the top collaborators of R. O. Peckinpaugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. O. Peckinpaugh. R. O. Peckinpaugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luther, Robert R., et al.. (1986). Carteolol Treatment of Essential Hypertension: A Long-Term Study of Safety and Efficacy. Journal of International Medical Research. 14(4). 175–184. 6 indexed citations
2.
Edwards, Earl A., et al.. (1976). A LONGITUDINAL STUDY OF MYCOPLASMA PNEUMONIAE: INFECTIONS IN NAVY RECRUITS BY ISOLATION AND SEROEPIDEMIOLOGY. American Journal of Epidemiology. 104(5). 556–562. 16 indexed citations
3.
Edwards, Earl A., et al.. (1975). Recent Experiences with Live Adenovirus Vaccines in Navy Recruits. Military Medicine. 140(4). 251–257. 6 indexed citations
4.
Edwards, E. A., David Johnson, W. E. Pierce, & R. O. Peckinpaugh. (1974). Reactions and serologic responses to monovalent acetone-inactivated typhoid vaccine and heat-killed TAB when given by jet injection.. PubMed. 51(5). 501–5. 10 indexed citations
5.
Devine, Leonard F., et al.. (1973). Minocycline and rifampin: proposed treatment regimen for the elimination of meningococci from the nasopharynges of healthy carriers.. PubMed. 138(1). 20–4. 3 indexed citations
6.
Devine, Leonard F., et al.. (1973). FIELD TRIAL OF THE EFFICACY OF A PREVIOUSLY PROPOSED REGIMEN USING MINOCYCLINE AND RIFAMPIN SEQUENTIALLY FOR THE ELIMINATION OF MENINGOCOCCI FROM HEALTHY CARRIERS1. American Journal of Epidemiology. 97(6). 394–401. 23 indexed citations
7.
Devine, Leonard F., et al.. (1972). Selective minocycline and rifampin treatment of group C meningococcal carriers in a new naval recruit camp. The American Journal of the Medical Sciences. 263(2). 79–94. 6 indexed citations
8.
Kory, Ross C., et al.. (1972). Electron Microscope Methods for the Identification of Adenoviruses Isolated in Micro Tissue Cultures. Applied Microbiology. 23(1). 141–144. 4 indexed citations
9.
Devine, Leonard F., et al.. (1971). THE EFFECT OF MINOCYCLINE ON MENINGOCOCCAL NASOPHARYNGEAL CARRIER STATE IN NAVAL PERSONNEL1. American Journal of Epidemiology. 93(5). 337–345. 33 indexed citations
10.
Devine, Leonard F., et al.. (1971). Rifampin: effect of two-day treatment on the meningococcal carrier state and the relationship to the levels of drug in sera and saliva. The American Journal of the Medical Sciences. 261(2). 79–83. 18 indexed citations
11.
Edwards, E. A., et al.. (1971). Serologic Surveillance for Adeno-Associated Satellite Virus Antibody in Military Recruits. The Journal of Immunology. 106(3). 711–720. 3 indexed citations
12.
Peckinpaugh, R. O., et al.. (1970). The Bacteria-Like Chlamydiae of Ornithosis and the Diseases they Cause. CRC Critical Reviews in Clinical Laboratory Sciences. 1(3). 451–470. 2 indexed citations
13.
Peckinpaugh, R. O., et al.. (1970). FIELD STUDIES WITH AMANTADINE: ACCEPTABILITY AND PROTECTION. Annals of the New York Academy of Sciences. 173(1). 62–73. 20 indexed citations
14.
Peckinpaugh, R. O., et al.. (1968). Mass enteric live adenovirus vaccination during epidemic ARD [acute respiratory disease].. JAMA. 205(1). 5–10. 2 indexed citations
15.
Sullivan, Elizabeth J., E. A. Edwards, W. E. Pierce, et al.. (1968). CHARACTERISTICS OF VACCINE-INDUCED AND NATURAL INFECTION WITH ADENOVIRUS TYPE 4 IN NAVAL RECRUITS1. American Journal of Epidemiology. 88(1). 45–54. 9 indexed citations
16.
Peckinpaugh, R. O.. (1968). Mass Enteric Live Adenovirus Vaccination During Epidemic ARD. JAMA. 205(1). 5–5. 31 indexed citations
17.
Peckinpaugh, R. O.. (1968). Mass enteric live adenovirus vaccination during epidemic ARD. JAMA. 205(1). 75–80. 5 indexed citations
18.
Pierce, W. E., et al.. (1968). LIVE AND INACTIVATED ADENOVIRUS VACCINES FOR THE PREVENTION OF ACUTE RESPIRATORY ILLNESS IN NAVAL RECRUITS1. American Journal of Epidemiology. 87(1). 237–246. 21 indexed citations
19.
Pierce, W. E., et al.. (1965). Epidemiology and Prevention of Acute Respiratory Disease in Naval Recruits. American Journal of Public Health and the Nations Health. 55(1). 67–80. 19 indexed citations
20.
Peckinpaugh, R. O., et al.. (1965). Epidemiology and Prevention of Acute Respiratory Disease in Naval Recruits. American Journal of Public Health and the Nations Health. 55(1). 47–59. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026